SEC Form 4 · accession 0001179110-18-011045
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Lane
Officer — Executive Vice President
Period of report
Aug 29, 2018
Accepted (ET)
Aug 31, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Aug 29, 2018 | S | 100 | $67.121 | D | 35,576 | D | |
| Common shares without par value | Aug 29, 2018 | S | 8,697 | $67.111 | D | 26,879 | D | |
| Common shares without par value | Aug 29, 2018 | S | 100 | $67.12 | D | 26,779 | D | |
| Common shares without par value | Aug 29, 2018 | S | 100 | $67.1201 | D | 26,679 | D | |
| Common shares without par valueF1 | Aug 29, 2018 | S | 100 | $67.121 | D | 26,583 | D | |
| Common shares without par valueF2 | holding | — | — | — | 1,247 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares acquired pursuant to a dividend reinvestment feature.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of August 29, 2018.